Evidence map›Paper›PMID 26509652›Full record

ArticleMagnetic resonance in medicine2016

Bloch-Siegert B1+-mapping for human cardiac (31) P-MRS at 7 Tesla.

William T Clarke, Matthew D Robson, Christopher T Rodgers

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in Magnetic resonance in medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Repeatability of Rapid Human Cardiac Phosphorus MRSI (Magnetic resonance in medicine · 2026
    Article
  3. Article
  4. Fast 3DMagnetic resonance in medicine · 2025
    Article
  5. Fast 3DArXiv · 2024
    Article
  6. CardiacHeart failure reviews · 2023
    Review
  7. Clinically feasible BNMR in biomedicine · 2023
    Article
  8. Feasibility ofNMR in biomedicine · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Adiabatic excitation forMagnetic resonance in medicine · 2017
    Article
  13. Article
  14. In-vivoAnalytical biochemistry · 2017
    Review
  15. Review
  16. Article
  17. Article
  18. ECG Triggering in Ultra-High Field Cardiovascular MRI.Tomography (Ann Arbor, Mich.) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

William T ClarkeOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Level 0, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom. william.clarke@cardiov.ox.ac.uk.ORCID 0000-0001-7159-7025
Matthew D RobsonOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Level 0, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Christopher T RodgersOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Level 0, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
John Radcliffe Hospital · GB

Funding

Medical Research Council G0700796Medical Research Council G0900883Wellcome Trust 098436
6 · The paper itself

Abstract

purposePhosphorus MR spectroscopy ((31) P-MRS) is a powerful tool for investigating tissue energetics in vivo. Cardiac (31) P-MRS is typically performed using surface coils that create an inhomogeneous excitation field across the myocardium. Accurate measurements of B1+ (and hence flip angle) are necessary for quantitative analysis of (31) P-MR spectra. We demonstrate a Bloch-Siegert B1+-mapping method for this purpose. THEORY AND

methodsWe compare acquisition strategies for Bloch-Siegert B1+-mapping when there are several spectral peaks. We optimize a Bloch-Siegert sensitizing (Fermi) pulse for cardiac (31) P-MRS at 7 Tesla (T) and apply it in a three-dimensional (3D) chemical shift imaging sequence. We validate this in phantoms and skeletal muscle (against a dual-TR method) and present the first cardiac (31) P B1+-maps at 7T.

resultsThe Bloch-Siegert method correlates strongly (Pearson's r = 0.90 and 0.84) and has bias <25 Hz compared with a multi-TR method in phantoms and dual-TR method in muscle. Cardiac 3D B1+-maps were measured in five normal volunteers. B1+ maps based on phosphocreatine and alpha-adenosine-triphosphate correlated strongly (r = 0.62), confirming that the method is T1 insensitive.

conclusionThe 3D (31) P Bloch-Siegert B1+-mapping is consistent with reference methods in phantoms and skeletal muscle. It is the first method appropriate for (31) P B1+-mapping in the human heart at 7T. Magn Reson Med 76:1047-1058, 2016. © 2015 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Indexed as

AlgorithmsAdenosine TriphosphateHeartHumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMolecular ImagingMyocardiumPhosphorus IsotopesRadiopharmaceuticalsReproducibility of ResultsSensitivity and SpecificityTissue DistributionAdenosine TriphosphatePhosphorus IsotopesRadiopharmaceuticals31P-MRS7TB1+-mappingBloch-Siegertcardiacheartphosphorusspectroscopy

Identifiers

PMID26509652
PMCPMC5076794
OpenAlexW2151259746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.